Clinical Study Reports MDMA, aka Ecstasy or Molly, Dramatically helps PTSD when Combined with Therapy

Diane Lilli

A new clinical study reporting Post Traumatic Stress Syndrome (PTSD) patients experience relief from MDMA, known also as Ecstasy or Molly, will be published in Nature Medicine at the end of May.

PTSD is a severe condition resulting from emotional trauma, and impacts many millions of people, especially combat veterans.

The new study tested the effects of MDMA upon ninety subjects and reported the still-illegal drug therapy offered a significant reduction in their symptoms of PTSD.

The study included both MDMA plus therapy, working in conjunction to reap successful results.

This study reports that 67 percent of the participants, who began their therapy with a diagnosis of PTSD, no longer were diagnosed with the condition after the MDMS therapy. The clinical study reports that 32 percent of participants were also treated successfully within the placebo group, perhaps because they received therapy treatments.

The study included both MDMA plus therapy, working in conjunction to reap successful results.

The MDMA coupled with therapy may offer the brain relief and help heal traumatic memories, though the final proof of this successful therapy is not yet defined in full. This clinical study seems to prove that it’s the combination of both MDMA and therapy treatment that offers patients results and relief from PTSD.

A new Phase 3 study is underway with 100 participants.

The FDA has not yet approved MDMA for therapy, but there if a second Phase 3 trial reports positive results, the approval can arrive within two years.

MDMA was created in 1912 by Merck and was initially used by numerous therapists in the 1970s by therapists, who reported dramatic positive results in months instead of decades. The drug became highly popular and was renamed Ecstasy by users, who purchased it illegally for recreational use.


No comments on this item Please log in to comment by clicking here